Amondina, Sheryl .
HRN: 09-16-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2025
CEFUROXIME 500MG (TAB)
04/01/2025
04/08/2025
ORAL
500mg
BID
Sp NSVD; UTI
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes